ACTCD the future in bio-tech: Making money on ASTY and ACTCD

ACTCD the future in bio-tech: Making money on ASTY and ACTCD: That's unusual, believe me, I've had to pinch myself. They are the future IMO. Check them out. I would not buy now. They both have r...

Making money on ASTY and ACTCD

That's unusual, believe me, I've had to pinch myself. They are the future IMO. Check them out. I would not buy now. They both have run up [it's possible they will run a little more.] Still own a little GERN, they broke my heart and I've lost many dollars. GERN has just one drug left, if it fails, it's all over, if it hits, the sky is the limit. Good luck in this rigged casino.

ACTC the future in bio-tech: Clinical Trial Hold Of Geron's Revolutionary Drug ...

ACTC the future in bio-tech: Clinical Trial Hold Of Geron's Revolutionary Drug ...: •The clinical hold does not currently affect the Mayo sponsored Myelofibrosis clinical trial. •EV patients had been on treatment for an aver...

Clinical Trial Hold Of Geron's Revolutionary Drug Imetelstat Will Be Temporary

•The clinical hold does not currently affect the Mayo sponsored Myelofibrosis clinical trial. •EV patients had been on treatment for an average of 14 months, with the longest being 2.5 years without any progression of LFT abnormalities. •Current price provides risk tolerant investors a significant opportunity to double their investment in a short period of time. That's great news, but everyone should have known that. It moved the stock price up 8% and my Calls are worth $300+. When the Hold is lifted a $1 move should happen and I will sell most of my Calls. Good luck in this rigged casino.

ACTC the future in bio-tech: More Bad News for Geron

ACTC the future in bio-tech: More Bad News for Geron: They're the gang that can't shoot straight. GERN) : Co announces that the company has received verbal notice from FDA that its Inves...

More Bad News for Geron

They're the gang that can't shoot straight. GERN) : Co announces that the company has received verbal notice from FDA that its Investigational New Drug application for imetelstat has been placed on full clinical hold, affecting all ongoing company- sponsored clinical trials. •A full clinical hold is an order that the FDA issues to a trial sponsor to suspend an ongoing clinical trial or delay a proposed trial. The clinical hold affects the remaining eight patients in the company's Phase 2 study in essential thrombocythemia or polycythemia vera and the remaining two patients in the company's Phase 2 study in multiple myeloma. •In addition, the company's planned Phase 2 clinical trial in myelofibrosis will likely be delayed due to the clinical hold. It is possible that other studies using imetelstat, such as ongoing investigator-sponsored trials, may also be placed on clinical hold by the FDA. I'm so glad I sold 90% of the stock in Geron, I wish I sold it at $7 which it hit for very short time a few months and not at below $3 but that's the way it goes. What's upsetting to me is Geron said imetelstat had very few side effects. This is there only drug left. Six trials and only one worked out, this one, the imetelstat. I'm guessing Geron will get the new trials going in a few months [guessing 6 months which would made it in Sept] I made a bet [and that what it is] that when the trials are OK'd by the FDA, and the stock will go up. I got 25 $5 calls for Jan 2016 for 45 cents today. Lets see if the bet pays off. Stock closed at $1.69 on 46 million shares, down over $2.70. Good luck in this rigged casino.